臨床試験用品市場- 世界の産業規模、シェア、動向、機会、予測、臨床フェーズ別、製品・サービス別、治療用途別、エンドユーザー別、地域別、競合別、2020-2030F

臨床試験用品の世界市場規模は2024年に28億1,000万米ドルとなり、2030年までのCAGRは7.43%で、2030年には43億3,000万米ドルに達すると予測されています。

世界的に臨床試験の量と複雑さが増しているため、市場は持続的な成長を遂げています。製薬・バイオ医薬品企業が新治療法の開発加速を目指す中、合理的で信頼性が高く、コンプライアンスに準拠したサプライチェーンへの需要が高まっています。臨床試験は地理的に分散し、期間も長くなり、規制要件も厳しくなっています。このため、効率的なロジスティクス、温度管理された保管、リアルタイムの追跡システムの必要性が高まっています。適応性の高い臨床試験デザインと個別化医療の採用は、供給プロセスをさらに複雑にしており、スポンサーは柔軟で拡張性のある供給パートナーを求めています。

市場を形成する重要な動向は、臨床試験ロジスティクスにおけるデジタル技術の統合です。分散型およびハイブリッド型臨床試験モデルの台頭により、治験依頼者と開発業務受託機関（CRO）はDTP（Direct to Patient）供給戦略を採用し、モニタリング、予測、在庫管理にデジタルツールを採用するようになっています。需要計画やデータ分析のための高度なソフトウェアプラットフォームの導入は、無駄の削減、精度の向上、リアルタイムの意思決定に役立っています。スマートパッケージング、データセキュリティのためのブロックチェーン、AI主導の予測などのイノベーションは、業務効率の向上と規制遵守の確保に活用されています。

主な市場促進要因

治療領域にわたる臨床試験数の増加

主な市場課題

世界サプライチェーン管理の複雑さ

主な市場動向

サプライチェーンのデジタル化とリアルタイムモニタリングの採用増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の臨床試験用品市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 臨床段階別（フェーズI、フェーズII、フェーズIII、その他）
  • 製品・サービス別（製造、保管・配送、サプライチェーン管理）
  • 治療用途別（腫瘍学、中枢神経系疾患、心血管疾患、感染症、代謝疾患、その他）
  • エンドユーザー別（医薬品、生物製剤、医療機器、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の臨床試験用品市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の臨床試験用品市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の臨床試験用品市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の臨床試験用品市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの臨床試験用品市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific Inc.
• Almac Group
• Novo Holdings A/S
• Marken（UPS）
• PCI Pharma Services
• Sharp Services LLC
• Cencora, Inc.
• Myonex
• Parexel International Corporation
• ICON Plc

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Clinical Trial Supplies Market was valued at USD 2.81 billion in 2024 and is expected to reach USD 4.33 billion by 2030, growing at a CAGR of 7.43% through 2030. The market is experiencing sustained growth due to the increasing volume and complexity of clinical trials globally. As pharmaceutical and biopharmaceutical companies aim to accelerate the development of new therapies, the demand for streamlined, reliable, and compliant supply chains has intensified. Clinical trials are becoming more geographically dispersed, longer in duration, and subject to stricter regulatory requirements. This increases the need for efficient logistics, temperature-controlled storage, and real-time tracking systems. The adoption of adaptive trial designs and personalized medicine is further complicating the supply process, prompting sponsors to seek supply partners with flexible and scalable capabilities.

A significant trend shaping the market is the integration of digital technologies in clinical trial logistics. The rise of decentralized and hybrid trial models is pushing sponsors and contract research organizations (CROs) to adopt direct-to-patient (DTP) supply strategies and employ digital tools for monitoring, forecasting, and inventory control. The implementation of advanced software platforms for demand planning and data analytics is helping reduce waste, improve accuracy, and support real-time decision-making. Innovations like smart packaging, blockchain for data security, and AI-driven forecasting are being leveraged to enhance operational efficiency and ensure regulatory compliance.

Key Market Drivers

Rising Number of Clinical Trials Across Therapeutic Areas

The increasing number of clinical trials across various therapeutic areas is a key driver for the Global Clinical Trial Supplies Market. Pharmaceutical, biotechnology, and medical device companies are expanding their research and development pipelines, leading to a surge in clinical research activities. This growth is fueled by increased investments in drug discovery and innovation, along with the growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune conditions. As new molecules and biologics enter the clinical stage, the demand for efficient and reliable supply chains becomes critical. Sponsors require specialized logistics and packaging services to support complex trial protocols, manage temperature-sensitive products, and ensure the timely delivery of investigational medicinal products (IMPs) to global trial sites.

According to the World Health Organization's International Clinical Trials Registry Platform (ICTRP), the number of newly recruiting trials has steadily increased, with significant growth in regions such as South-East Asia, especially in India. This upward trend in clinical trial activity necessitates robust clinical trial supply chains to handle the increasing complexity and volume of trials. The rise of decentralized trials and direct-to-patient models has further emphasized the need for innovative supply strategies and cold chain infrastructure.

Key Market Challenges

Complexity in Managing Global Supply Chains

Managing global supply chains in the clinical trial supplies market presents significant logistical challenges. Clinical trials are increasingly conducted across multiple countries, complicating supply chain coordination due to varying timelines, different customs regulations, local language requirements, and multiple vendor engagements. Fluctuations in demand forecasts, unpredictable patient enrollment, and protocol amendments further strain supply planning and inventory management. Maintaining drug stability, ensuring timely delivery of investigational products, and preventing stockouts or wastage require highly responsive and adaptive systems. Specialized cold chain logistics and real-time monitoring become even more critical for temperature-sensitive drugs and biologics. As trials move toward decentralized models with direct-to-patient delivery and remote participation, the supply chain must evolve to remain flexible while maintaining quality and compliance. These challenges often add significant costs to trial budgets.

Key Market Trends

Increased Adoption of Supply Chain Digitalization and Real-Time Monitoring

The adoption of supply chain digitalization and real-time monitoring is transforming the operational landscape of the global clinical trial supplies market. Pharmaceutical sponsors and contract research organizations are prioritizing end-to-end visibility to manage the growing complexities of clinical trials. Digital platforms such as Interactive Response Technology (IRT), cloud-based inventory systems, and IoT-enabled tracking tools are becoming essential in enhancing supply chain responsiveness and transparency. These platforms provide real-time insights into drug availability, temperature control, and shipment progress, enabling supply managers to proactively address issues such as stockouts, wastage, and delays.

Real-time monitoring tools ensure compliance with stringent regulatory requirements by capturing data on temperature excursions, delivery confirmations, and chain-of-custody records. This is especially important for sensitive investigational products like biologics and personalized therapies. Predictive analytics integrated with these digital systems can forecast demand fluctuations and help optimize resupply strategies, improving trial continuity. Sponsors gain greater control, reducing risks and enhancing the patient experience by ensuring timely and reliable delivery of trial materials.

Key Market Players

• Thermo Fisher Scientific Inc.
• Almac Group
• Novo Holdings A/S
• Marken (UPS)
• PCI Pharma Services
• Sharp Services LLC
• Cencora, Inc.
• Myonex
• Parexel International Corporation
• ICON Plc

Report Scope:

In this report, the Global Clinical Trial Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Supplies Market, By Clinical Phase:

• Phase I
• Phase II
• Phase III
• Others

Clinical Trial Supplies Market, By Product & Services:

• Manufacturing
• Storage & Distribution
• Supply Chain Management

Clinical Trial Supplies Market, By Therapeutic Use:

• Oncology
• CNS Diseases
• Cardiovascular Diseases
• Infectious Disease
• Metabolic Disorders
• Others

Clinical Trial Supplies Market, By End User:

• Pharmaceutical
• Biologics
• Medical Device
• Others

Clinical Trial Supplies Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trial Supplies Market.

Available Customizations:

Global Clinical Trial Supplies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Clinical Trial Supplies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Clinical Phase (Phase I, Phase II, Phase III, Others)
  • 5.2.2. By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management)
  • 5.2.3. By Therapeutic Use (Oncology, CNS Diseases, Cardiovascular Diseases, Infectious Disease, Metabolic Disorders, Others)
  • 5.2.4. By End User (Pharmaceutical, Biologics, Medical device, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Clinical Trial Supplies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Clinical Phase
  • 6.2.2. By Product & Services
  • 6.2.3. By Therapeutic Use
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Clinical Trial Supplies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Clinical Phase
      • 6.3.1.2.2. By Product & Services
      • 6.3.1.2.3. By Therapeutic Use
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Clinical Trial Supplies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Clinical Phase
      • 6.3.2.2.2. By Product & Services
      • 6.3.2.2.3. By Therapeutic Use
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Clinical Trial Supplies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Clinical Phase
      • 6.3.3.2.2. By Product & Services
      • 6.3.3.2.3. By Therapeutic Use
      • 6.3.3.2.4. By End User

7. Europe Clinical Trial Supplies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Clinical Phase
  • 7.2.2. By Product & Services
  • 7.2.3. By Therapeutic Use
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Clinical Trial Supplies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Clinical Phase
      • 7.3.1.2.2. By Product & Services
      • 7.3.1.2.3. By Therapeutic Use
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Clinical Trial Supplies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Clinical Phase
      • 7.3.2.2.2. By Product & Services
      • 7.3.2.2.3. By Therapeutic Use
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Clinical Trial Supplies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Clinical Phase
      • 7.3.3.2.2. By Product & Services
      • 7.3.3.2.3. By Therapeutic Use
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Clinical Trial Supplies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Clinical Phase
      • 7.3.4.2.2. By Product & Services
      • 7.3.4.2.3. By Therapeutic Use
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Clinical Trial Supplies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Clinical Phase
      • 7.3.5.2.2. By Product & Services
      • 7.3.5.2.3. By Therapeutic Use
      • 7.3.5.2.4. By End User

8. Asia-Pacific Clinical Trial Supplies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Clinical Phase
  • 8.2.2. By Product & Services
  • 8.2.3. By Therapeutic Use
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Clinical Trial Supplies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Clinical Phase
      • 8.3.1.2.2. By Product & Services
      • 8.3.1.2.3. By Therapeutic Use
      • 8.3.1.2.4. By End User
  • 8.3.2. India Clinical Trial Supplies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Clinical Phase
      • 8.3.2.2.2. By Product & Services
      • 8.3.2.2.3. By Therapeutic Use
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Clinical Trial Supplies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Clinical Phase
      • 8.3.3.2.2. By Product & Services
      • 8.3.3.2.3. By Therapeutic Use
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Clinical Trial Supplies Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Clinical Phase
      • 8.3.4.2.2. By Product & Services
      • 8.3.4.2.3. By Therapeutic Use
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Clinical Trial Supplies Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Clinical Phase
      • 8.3.5.2.2. By Product & Services
      • 8.3.5.2.3. By Therapeutic Use
      • 8.3.5.2.4. By End User

9. South America Clinical Trial Supplies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Clinical Phase
  • 9.2.2. By Product & Services
  • 9.2.3. By Therapeutic Use
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Clinical Trial Supplies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Clinical Phase
      • 9.3.1.2.2. By Product & Services
      • 9.3.1.2.3. By Therapeutic Use
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Clinical Trial Supplies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Clinical Phase
      • 9.3.2.2.2. By Product & Services
      • 9.3.2.2.3. By Therapeutic Use
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Clinical Trial Supplies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Clinical Phase
      • 9.3.3.2.2. By Product & Services
      • 9.3.3.2.3. By Therapeutic Use
      • 9.3.3.2.4. By End User

10. Middle East and Africa Clinical Trial Supplies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Clinical Phase
  • 10.2.2. By Product & Services
  • 10.2.3. By Therapeutic Use
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Clinical Trial Supplies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Clinical Phase
      • 10.3.1.2.2. By Product & Services
      • 10.3.1.2.3. By Therapeutic Use
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Clinical Trial Supplies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Clinical Phase
      • 10.3.2.2.2. By Product & Services
      • 10.3.2.2.3. By Therapeutic Use
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Clinical Trial Supplies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Clinical Phase
      • 10.3.3.2.2. By Product & Services
      • 10.3.3.2.3. By Therapeutic Use
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Almac Group
• 14.3. Novo Holdings A/S
• 14.4. Marken (UPS)
• 14.5. PCI Pharma Services
• 14.6. Sharp Services LLC
• 14.7. Cencora, Inc.
• 14.8. Myonex
• 14.9. Parexel International Corporation
• 14.10. ICON Plc

15. Strategic Recommendations

16. About Us & Disclaimer